Jnba Financial Advisors Zoetis Inc. Transaction History

Jnba Financial Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$148.29 - $182.55 $10,973 - $13,508	-74 Reduced 86.05%	12 $2,000
Q1 2022 Apr 29, 2022	BUY	$181.39 - $234.03 $12,878 - $16,616	71 Added 473.33%	86 $16,000
Q4 2021 Feb 03, 2022	SELL	$193.69 - $247.03 $38,156 - $48,664	-197 Reduced 92.92%	15 $4,000
Q3 2021 Nov 10, 2021	BUY	$189.29 - $209.69 $40,129 - $44,454	212 New	212 $41,000
Q3 2019 Nov 01, 2019	SELL	$112.57 - $128.43 $14,296 - $16,310	-127 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$97.98 - $114.28 $9,798 - $11,428	100 Added 370.37%	127 $14,000
Q4 2018 Feb 07, 2019	BUY	$79.28 - $95.27 $2,140 - $2,572	27 New	27 $2,000
Q3 2018 Nov 01, 2018	SELL	$83.5 - $93.23 $2,254 - $2,517	-27 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	27	27 $2,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Jnba Financial Advisors with notifications on news.